Increased virus replication in mammalian cells by blocking intracellular innate defense responses

The mammalian innate immune system senses viral infection by recognizing viral signatures and activates potent antiviral responses. Besides the interferon (IFN) response, there is accumulating evidence that RNA silencing or RNA interference (RNAi) serves as an antiviral mechanism in mammalian cells. Mammalian viruses encode IFN antagonists to counteract the IFN response in infected cells. A number of IFN antagonists are also capable of blocking RNAi in infected cells and therefore serve as RNA-silencing suppressors. Virus replication in infected cells is restricted by these innate antiviral mechanisms, which may kick in earlier than the viral antagonistic or suppressor protein can accumulate. The yield of virus vaccines and viral gene delivery vectors produced in mammalian producer cells may therefore be suboptimal. To investigate whether blocking of the innate antiviral responses in mammalian cells leads to increased viral vector production, we expressed a number of immunity suppressors derived from plant and mammalian viruses in human cells. We measured that the yield of infectious human immunodeficiency virus-1 particles produced in these cells was increased 5- to 10-fold. In addition, the production of lentiviral and adenoviral vector particles was increased 5- to 10-fold, whereas Sindbis virus particle production was increased approximately 100-fold. These results can be employed for improving the production of viral gene transfer vectors and viral vaccine strains.

[1]  B. Berkhout,et al.  Inhibition of virus replication by RNA interference. , 2003, Journal of biomedical science.

[2]  K. Kok,et al.  Human TRBP and PACT Directly Interact with Each Other and Associate with Dicer to Facilitate the Production of Small Interfering RNA* , 2007, Journal of Biological Chemistry.

[3]  G. Sen,et al.  PACT, a protein activator of the interferon‐induced protein kinase, PKR , 1998, The EMBO journal.

[4]  Michael Karin,et al.  Intracellular pattern recognition receptors in the host response , 2006, Nature.

[5]  Khaled Machaca,et al.  RNA interference is an antiviral defence mechanism in Caenorhabditis elegans , 2005, Nature.

[6]  H. Klenk,et al.  The Ebola Virus VP35 Protein Inhibits Activation of Interferon Regulatory Factor 3 , 2003, Journal of Virology.

[7]  Stefano Volinia,et al.  Interferon modulation of cellular microRNAs as an antiviral mechanism , 2007, Nature.

[8]  L. Tsai,et al.  BACE1 Suppression by RNA Interference in Primary Cortical Neurons* , 2004, Journal of Biological Chemistry.

[9]  V. Kim,et al.  The role of PACT in the RNA silencing pathway , 2006, The EMBO journal.

[10]  T. Mak,et al.  HIV-1 Tat directly interacts with the interferon-induced, double-stranded RNA-dependent kinase, PKR. , 1995, Virology.

[11]  Ravi Sachidanandam,et al.  A germline-specific class of small RNAs binds mammalian Piwi proteins , 2006, Nature.

[12]  H. Soifer,et al.  A potential role for RNA interference in controlling the activity of the human LINE-1 retrotransposon , 2005, Nucleic acids research.

[13]  K. Moelling,et al.  Dicer is involved in protection against influenza A virus infection. , 2007, The Journal of general virology.

[14]  K. Lundstrom Biology and application of alphaviruses in gene therapy , 2005, Gene Therapy.

[15]  G. Szittya,et al.  Size Selective Recognition of siRNA by an RNA Silencing Suppressor , 2003, Cell.

[16]  Shou-Wei Ding,et al.  Interferon antagonist proteins of influenza and vaccinia viruses are suppressors of RNA silencing. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[17]  A. Fire,et al.  Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans , 1998, Nature.

[18]  Donald B Kohn,et al.  Lentiviral vectors ready for prime-time , 2007, Nature Biotechnology.

[19]  B. Berkhout,et al.  The Ebola Virus VP35 Protein Is a Suppressor of RNA Silencing , 2007, PLoS pathogens.

[20]  Tariq M Rana,et al.  Small RNAs: Regulators and guardians of the genome , 2007, Journal of cellular physiology.

[21]  T. Tuschl,et al.  Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells , 2001, Nature.

[22]  D. Bartel MicroRNAs Genomics, Biogenesis, Mechanism, and Function , 2004, Cell.

[23]  R. Krug,et al.  The primary function of RNA binding by the influenza A virus NS1 protein in infected cells: Inhibiting the 2'-5' oligo (A) synthetase/RNase L pathway. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[24]  A. Saïb,et al.  A Cellular MicroRNA Mediates Antiviral Defense in Human Cells , 2005, Science.

[25]  R. Carthew,et al.  Methods and Materials , 1956, Eco-Art Therapy in Practice.

[26]  Xuemin Zhang,et al.  Evidence that RNA silencing functions as an antiviral defense mechanism in fungi , 2007, Proceedings of the National Academy of Sciences.

[27]  Erica Ollmann Saphire,et al.  Ebola Virus VP35 Protein Binds Double-Stranded RNA and Inhibits Alpha/Beta Interferon Production Induced by RIG-I Signaling , 2006, Journal of Virology.

[28]  D. Valerio,et al.  Generation of a high-capacity hybrid vector: packaging of recombinant adenoassociated virus replicative intermediates in adenovirus capsids overcomes the limited cloning capacity of adenoassociated virus vectors. , 2001, Virology.

[29]  D. Levy,et al.  Influenza A virus lacking the NS1 gene replicates in interferon-deficient systems. , 1998, Virology.

[30]  Jialing Huang,et al.  Cellular microRNAs contribute to HIV-1 latency in resting primary CD4+ T lymphocytes , 2007, Nature Medicine.

[31]  S. Akira,et al.  The role of Toll-like receptors in immune disorders , 2006, Expert opinion on biological therapy.

[32]  Gene W Yeo,et al.  RNA sequence analysis defines Dicer's role in mouse embryonic stem cells , 2007, Proceedings of the National Academy of Sciences.

[33]  B. Berkhout,et al.  Inhibition of human immunodeficiency virus type 1 by RNA interference using long-hairpin RNA , 2006, Gene Therapy.

[34]  P. Sinn,et al.  Gene Therapy Progress and Prospects: Development of improved lentiviral and retroviral vectors – design, biosafety, and production , 2005, Gene Therapy.

[35]  K. Jeang,et al.  Oncogenic potential of TAR RNA binding protein TRBP and its regulatory interaction with RNA‐dependent protein kinase PKR , 1997, The EMBO journal.

[36]  S. Le,et al.  Evidence that HIV-1 encodes an siRNA and a suppressor of RNA silencing. , 2005, Immunity.

[37]  Sanghyuk Lee,et al.  MicroRNA genes are transcribed by RNA polymerase II , 2004, The EMBO journal.

[38]  B. Berkhout,et al.  RNA interference against viruses: strike and counterstrike , 2007, Nature Biotechnology.

[39]  E. Bucher,et al.  The influenza A virus NS1 protein binds small interfering RNAs and suppresses RNA silencing in plants. , 2004, The Journal of general virology.

[40]  K. Ishii,et al.  Differential roles of MDA5 and RIG-I helicases in the recognition of RNA viruses , 2006, Nature.

[41]  R. Silverman,et al.  Small self-RNA generated by RNase L amplifies antiviral innate immunity , 2007, Nature.

[42]  Yong‐jun Liu,et al.  IPC: professional type 1 interferon-producing cells and plasmacytoid dendritic cell precursors. , 2005, Annual review of immunology.

[43]  V. Volchkov,et al.  The Ebola virus VP35 protein functions as a type I IFN antagonist. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[44]  B. Williams,et al.  HIV-I TAT inhibits PKR activity by both RNA-dependent and RNA-independent mechanisms. , 2000, Archives of biochemistry and biophysics.

[45]  P. Zamore,et al.  ATP Requirements and Small Interfering RNA Structure in the RNA Interference Pathway , 2001, Cell.

[46]  D. McDonald,et al.  Visualization of the intracellular behavior of HIV in living cells , 2002, The Journal of cell biology.

[47]  A. Pasquinelli,et al.  A Cellular Function for the RNA-Interference Enzyme Dicer in the Maturation of the let-7 Small Temporal RNA , 2001, Science.

[48]  Pascal Barbry,et al.  Suppression of MicroRNA-Silencing Pathway by HIV-1 During Virus Replication , 2007, Science.

[49]  J. Ruijter,et al.  Factor correction as a tool to eliminate between-session variation in replicate experiments: application to molecular biology and retrovirology , 2006, Retrovirology.

[50]  S. Hammond,et al.  An RNA-directed nuclease mediates post-transcriptional gene silencing in Drosophila cells , 2000, Nature.

[51]  L. Stamatatos,et al.  Antibody mediated protection of immunized macaques against pathogenic SHIV challenge , 2006, Retrovirology.

[52]  K. Kasschau,et al.  A Counterdefensive Strategy of Plant Viruses Suppression of Posttranscriptional Gene Silencing , 1998, Cell.